Access to Nonstatin Lipid-Lowering Therapies in Patients at High Risk of Atherosclerotic Cardiovascular Disease
- 30 May 2017
- journal article
- letter
- Published by Wolters Kluwer Health in Circulation
- Vol. 135 (22) , 2204-2206
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular DiseaseNew England Journal of Medicine, 2017
- Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United StatesCirculation: Cardiovascular Genetics, 2016
- The Agenda for Familial HypercholesterolemiaCirculation, 2015
- 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in AdultsCirculation, 2014
- Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular geneticsThe American Journal of Cardiology, 1993